TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Operating cash flow 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$1.6BFY2025 · since FY2016: $3.9B → $1.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.6B | +32.2% |
| FY2024 | $1.2B | -8.8% |
| FY2023 | $1.4B | -14.0% |
| FY2022 | $1.6B | +99.2% |
| FY2021 | $798.0M | -34.4% |
| FY2020 | $1.2B | +62.6% |
| FY2019 | $748.0M | -69.4% |
| FY2018 | $2.4B | +9.9% |
| FY2017 | $2.2B | -42.8% |
| FY2016 | $3.9B | — |
Source: SEC XBRL filings · For reference only · Not investment advice